Amgen Stock Flirts With Breakout After Prevailing In Enbrel Patent Battle – Investor's Business Daily

This post was originally published on this site

[unable to retrieve full-text content]Amgen Stock Flirts With Breakout After Prevailing In Enbrel Patent Battle  Investor’s Business Daily

Amgen stock is nearing a breakout after the biotech company won a patent battle against Novartis, protecting nearly $5 billion in 2019 U.S. Enbrel sales.

This post was originally published on *this site*